New CEO appointments include Idorsia, Arrakis leaders

Jean-Paul Clozel’s temporary return to the CEO role at Idorsia Ltd. (SIX:IDIA) is due to end on Oct. 1, when Roland Wandeler assumes the role. Clozel has been interim CEO since March, when Srishti Gupta stepped down from the role; NovaBridge Biosciences said last week that Gupta has become its next CEO. Wandeler will join from Grifols S.A. (Madrid:GRF; NASDAQ:GRFS), where he is president of biopharma...